img

Global NARS Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global NARS Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Asparagine-tRNA ligase (NARS) belongs to the class-II aminoacyl-tRNA synthetase family.
NARS Antibody report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global NARS Antibody market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Immunochemistry (IHC) and Immunofluorescence (IF) are the major drivers for the industry.
Growing patient base, launch of NARS antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in NARS antibody market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global NARS Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
Bethyl Laboratories
EpiGentek
LifeSpan BioSciences
Biorbyt
RayBiotech
Abcam
Novus Biologicals
ProSci
ABclonal Technology
Abnova Corporation
Bioss
OriGene Technologies
Leading Biology
United States Biological
Sino Biological
HUABIO
NSJ Bioreagents
Jingjie PTM BioLab
Beijing Solarbio
Wuhan Fine Biotech
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the NARS Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, NARS Antibody introduction, etc. NARS Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of NARS Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of NARS Antibody
1.1 NARS Antibody Market Overview
1.1.1 NARS Antibody Product Scope
1.1.2 NARS Antibody Market Status and Outlook
1.2 Global NARS Antibody Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global NARS Antibody Market Size by Region (2018-2033)
1.4 Global NARS Antibody Historic Market Size by Region (2018-2023)
1.5 Global NARS Antibody Market Size Forecast by Region (2024-2033)
1.6 Key Regions, NARS Antibody Market Size (2018-2033)
1.6.1 North America NARS Antibody Market Size (2018-2033)
1.6.2 Europe NARS Antibody Market Size (2018-2033)
1.6.3 Asia-Pacific NARS Antibody Market Size (2018-2033)
1.6.4 Latin America NARS Antibody Market Size (2018-2033)
1.6.5 Middle East & Africa NARS Antibody Market Size (2018-2033)
2 NARS Antibody Market by Type
2.1 Introduction
2.1.1 Monoclonal
2.1.2 Polyclonal
2.2 Global NARS Antibody Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global NARS Antibody Historic Market Size by Type (2018-2023)
2.2.2 Global NARS Antibody Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America NARS Antibody Revenue Breakdown by Type (2018-2033)
2.3.2 Europe NARS Antibody Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific NARS Antibody Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America NARS Antibody Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa NARS Antibody Revenue Breakdown by Type (2018-2033)
3 NARS Antibody Market Overview by Application
3.1 Introduction
3.1.1 Immunochemistry (IHC)
3.1.2 Immunofluorescence (IF)
3.1.3 Immunoprecipitation (IP)
3.1.4 Western Blot (WB)
3.1.5 ELISA
3.1.6 Others
3.2 Global NARS Antibody Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global NARS Antibody Historic Market Size by Application (2018-2023)
3.2.2 Global NARS Antibody Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America NARS Antibody Revenue Breakdown by Application (2018-2033)
3.3.2 Europe NARS Antibody Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific NARS Antibody Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America NARS Antibody Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa NARS Antibody Revenue Breakdown by Application (2018-2033)
4 NARS Antibody Competition Analysis by Players
4.1 Global NARS Antibody Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NARS Antibody as of 2022)
4.3 Date of Key Players Enter into NARS Antibody Market
4.4 Global Top Players NARS Antibody Headquarters and Area Served
4.5 Key Players NARS Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 NARS Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck NARS Antibody Products, Services and Solutions
5.1.4 Merck NARS Antibody Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific NARS Antibody Products, Services and Solutions
5.2.4 Thermo Fisher Scientific NARS Antibody Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Proteintech Group
5.3.1 Proteintech Group Profile
5.3.2 Proteintech Group Main Business
5.3.3 Proteintech Group NARS Antibody Products, Services and Solutions
5.3.4 Proteintech Group NARS Antibody Revenue (US$ Million) & (2018-2023)
5.3.5 Aviva Systems Biology Recent Developments
5.4 Aviva Systems Biology
5.4.1 Aviva Systems Biology Profile
5.4.2 Aviva Systems Biology Main Business
5.4.3 Aviva Systems Biology NARS Antibody Products, Services and Solutions
5.4.4 Aviva Systems Biology NARS Antibody Revenue (US$ Million) & (2018-2023)
5.4.5 Aviva Systems Biology Recent Developments
5.5 Bethyl Laboratories
5.5.1 Bethyl Laboratories Profile
5.5.2 Bethyl Laboratories Main Business
5.5.3 Bethyl Laboratories NARS Antibody Products, Services and Solutions
5.5.4 Bethyl Laboratories NARS Antibody Revenue (US$ Million) & (2018-2023)
5.5.5 Bethyl Laboratories Recent Developments
5.6 EpiGentek
5.6.1 EpiGentek Profile
5.6.2 EpiGentek Main Business
5.6.3 EpiGentek NARS Antibody Products, Services and Solutions
5.6.4 EpiGentek NARS Antibody Revenue (US$ Million) & (2018-2023)
5.6.5 EpiGentek Recent Developments
5.7 LifeSpan BioSciences
5.7.1 LifeSpan BioSciences Profile
5.7.2 LifeSpan BioSciences Main Business
5.7.3 LifeSpan BioSciences NARS Antibody Products, Services and Solutions
5.7.4 LifeSpan BioSciences NARS Antibody Revenue (US$ Million) & (2018-2023)
5.7.5 LifeSpan BioSciences Recent Developments
5.8 Biorbyt
5.8.1 Biorbyt Profile
5.8.2 Biorbyt Main Business
5.8.3 Biorbyt NARS Antibody Products, Services and Solutions
5.8.4 Biorbyt NARS Antibody Revenue (US$ Million) & (2018-2023)
5.8.5 Biorbyt Recent Developments
5.9 RayBiotech
5.9.1 RayBiotech Profile
5.9.2 RayBiotech Main Business
5.9.3 RayBiotech NARS Antibody Products, Services and Solutions
5.9.4 RayBiotech NARS Antibody Revenue (US$ Million) & (2018-2023)
5.9.5 RayBiotech Recent Developments
5.10 Abcam
5.10.1 Abcam Profile
5.10.2 Abcam Main Business
5.10.3 Abcam NARS Antibody Products, Services and Solutions
5.10.4 Abcam NARS Antibody Revenue (US$ Million) & (2018-2023)
5.10.5 Abcam Recent Developments
5.11 Novus Biologicals
5.11.1 Novus Biologicals Profile
5.11.2 Novus Biologicals Main Business
5.11.3 Novus Biologicals NARS Antibody Products, Services and Solutions
5.11.4 Novus Biologicals NARS Antibody Revenue (US$ Million) & (2018-2023)
5.11.5 Novus Biologicals Recent Developments
5.12 ProSci
5.12.1 ProSci Profile
5.12.2 ProSci Main Business
5.12.3 ProSci NARS Antibody Products, Services and Solutions
5.12.4 ProSci NARS Antibody Revenue (US$ Million) & (2018-2023)
5.12.5 ProSci Recent Developments
5.13 ABclonal Technology
5.13.1 ABclonal Technology Profile
5.13.2 ABclonal Technology Main Business
5.13.3 ABclonal Technology NARS Antibody Products, Services and Solutions
5.13.4 ABclonal Technology NARS Antibody Revenue (US$ Million) & (2018-2023)
5.13.5 ABclonal Technology Recent Developments
5.14 Abnova Corporation
5.14.1 Abnova Corporation Profile
5.14.2 Abnova Corporation Main Business
5.14.3 Abnova Corporation NARS Antibody Products, Services and Solutions
5.14.4 Abnova Corporation NARS Antibody Revenue (US$ Million) & (2018-2023)
5.14.5 Abnova Corporation Recent Developments
5.15 Bioss
5.15.1 Bioss Profile
5.15.2 Bioss Main Business
5.15.3 Bioss NARS Antibody Products, Services and Solutions
5.15.4 Bioss NARS Antibody Revenue (US$ Million) & (2018-2023)
5.15.5 Bioss Recent Developments
5.16 OriGene Technologies
5.16.1 OriGene Technologies Profile
5.16.2 OriGene Technologies Main Business
5.16.3 OriGene Technologies NARS Antibody Products, Services and Solutions
5.16.4 OriGene Technologies NARS Antibody Revenue (US$ Million) & (2018-2023)
5.16.5 OriGene Technologies Recent Developments
5.17 Leading Biology
5.17.1 Leading Biology Profile
5.17.2 Leading Biology Main Business
5.17.3 Leading Biology NARS Antibody Products, Services and Solutions
5.17.4 Leading Biology NARS Antibody Revenue (US$ Million) & (2018-2023)
5.17.5 Leading Biology Recent Developments
5.18 United States Biological
5.18.1 United States Biological Profile
5.18.2 United States Biological Main Business
5.18.3 United States Biological NARS Antibody Products, Services and Solutions
5.18.4 United States Biological NARS Antibody Revenue (US$ Million) & (2018-2023)
5.18.5 United States Biological Recent Developments
5.19 Sino Biological
5.19.1 Sino Biological Profile
5.19.2 Sino Biological Main Business
5.19.3 Sino Biological NARS Antibody Products, Services and Solutions
5.19.4 Sino Biological NARS Antibody Revenue (US$ Million) & (2018-2023)
5.19.5 Sino Biological Recent Developments
5.20 HUABIO
5.20.1 HUABIO Profile
5.20.2 HUABIO Main Business
5.20.3 HUABIO NARS Antibody Products, Services and Solutions
5.20.4 HUABIO NARS Antibody Revenue (US$ Million) & (2018-2023)
5.20.5 HUABIO Recent Developments
5.21 NSJ Bioreagents
5.21.1 NSJ Bioreagents Profile
5.21.2 NSJ Bioreagents Main Business
5.21.3 NSJ Bioreagents NARS Antibody Products, Services and Solutions
5.21.4 NSJ Bioreagents NARS Antibody Revenue (US$ Million) & (2018-2023)
5.21.5 NSJ Bioreagents Recent Developments
5.22 Jingjie PTM BioLab
5.22.1 Jingjie PTM BioLab Profile
5.22.2 Jingjie PTM BioLab Main Business
5.22.3 Jingjie PTM BioLab NARS Antibody Products, Services and Solutions
5.22.4 Jingjie PTM BioLab NARS Antibody Revenue (US$ Million) & (2018-2023)
5.22.5 Jingjie PTM BioLab Recent Developments
5.23 Beijing Solarbio
5.23.1 Beijing Solarbio Profile
5.23.2 Beijing Solarbio Main Business
5.23.3 Beijing Solarbio NARS Antibody Products, Services and Solutions
5.23.4 Beijing Solarbio NARS Antibody Revenue (US$ Million) & (2018-2023)
5.23.5 Beijing Solarbio Recent Developments
5.24 Wuhan Fine Biotech
5.24.1 Wuhan Fine Biotech Profile
5.24.2 Wuhan Fine Biotech Main Business
5.24.3 Wuhan Fine Biotech NARS Antibody Products, Services and Solutions
5.24.4 Wuhan Fine Biotech NARS Antibody Revenue (US$ Million) & (2018-2023)
5.24.5 Wuhan Fine Biotech Recent Developments
6 North America
6.1 North America NARS Antibody Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe NARS Antibody Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NARS Antibody Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NARS Antibody Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NARS Antibody Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NARS Antibody Market Dynamics
11.1 NARS Antibody Industry Trends
11.2 NARS Antibody Market Drivers
11.3 NARS Antibody Market Challenges
11.4 NARS Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market NARS Antibody Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global NARS Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global NARS Antibody Market Size Share by Region (2018-2023)
Table 4. Global NARS Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global NARS Antibody Forecasted Market Size Share by Region (2024-2033)
Table 6. Global NARS Antibody Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global NARS Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global NARS Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global NARS Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global NARS Antibody Revenue Market Share by Type (2024-2033)
Table 11. North America NARS Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America NARS Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe NARS Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe NARS Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific NARS Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific NARS Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America NARS Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America NARS Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa NARS Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa NARS Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global NARS Antibody Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global NARS Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global NARS Antibody Revenue Market Share by Application (2018-2023)
Table 24. Global NARS Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global NARS Antibody Revenue Market Share by Application (2024-2033)
Table 26. North America NARS Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America NARS Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe NARS Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe NARS Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific NARS Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific NARS Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America NARS Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America NARS Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa NARS Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa NARS Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global NARS Antibody Revenue (US$ Million) by Players (2018-2023)
Table 37. Global NARS Antibody Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NARS Antibody as of 2022)
Table 39. Date of Key Players Enter into NARS Antibody Market
Table 40. Global NARS Antibody Key Players Headquarters and Area Served
Table 41. NARS Antibody Product Solution and Service
Table 42. Global NARS Antibody Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck Basic Information List
Table 45. Merck Description and Business Overview
Table 46. Merck NARS Antibody Products, Services and Solutions
Table 47. Revenue (US$ Million) in NARS Antibody Business of Merck (2018-2023)
Table 48. Merck Recent Developments
Table 49. Thermo Fisher Scientific Basic Information List
Table 50. Thermo Fisher Scientific Description and Business Overview
Table 51. Thermo Fisher Scientific NARS Antibody Products, Services and Solutions
Table 52. Revenue (US$ Million) in NARS Antibody Business of Thermo Fisher Scientific (2018-2023)
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. Proteintech Group Basic Information List
Table 55. Proteintech Group Description and Business Overview
Table 56. Proteintech Group NARS Antibody Products, Services and Solutions
Table 57. Revenue (US$ Million) in NARS Antibody Business of Proteintech Group (2018-2023)
Table 58. Proteintech Group Recent Developments
Table 59. Aviva Systems Biology Basic Information List
Table 60. Aviva Systems Biology Description and Business Overview
Table 61. Aviva Systems Biology NARS Antibody Products, Services and Solutions
Table 62. Revenue (US$ Million) in NARS Antibody Business of Aviva Systems Biology (2018-2023)
Table 63. Aviva Systems Biology Recent Developments
Table 64. Bethyl Laboratories Basic Information List
Table 65. Bethyl Laboratories Description and Business Overview
Table 66. Bethyl Laboratories NARS Antibody Products, Services and Solutions
Table 67. Revenue (US$ Million) in NARS Antibody Business of Bethyl Laboratories (2018-2023)
Table 68. Bethyl Laboratories Recent Developments
Table 69. EpiGentek Basic Information List
Table 70. EpiGentek Description and Business Overview
Table 71. EpiGentek NARS Antibody Products, Services and Solutions
Table 72. Revenue (US$ Million) in NARS Antibody Business of EpiGentek (2018-2023)
Table 73. EpiGentek Recent Developments
Table 74. LifeSpan BioSciences Basic Information List
Table 75. LifeSpan BioSciences Description and Business Overview
Table 76. LifeSpan BioSciences NARS Antibody Products, Services and Solutions
Table 77. Revenue (US$ Million) in NARS Antibody Business of LifeSpan BioSciences (2018-2023)
Table 78. LifeSpan BioSciences Recent Developments
Table 79. Biorbyt Basic Information List
Table 80. Biorbyt Description and Business Overview
Table 81. Biorbyt NARS Antibody Products, Services and Solutions
Table 82. Revenue (US$ Million) in NARS Antibody Business of Biorbyt (2018-2023)
Table 83. Biorbyt Recent Developments
Table 84. RayBiotech Basic Information List
Table 85. RayBiotech Description and Business Overview
Table 86. RayBiotech NARS Antibody Products, Services and Solutions
Table 87. Revenue (US$ Million) in NARS Antibody Business of RayBiotech (2018-2023)
Table 88. RayBiotech Recent Developments
Table 89. Abcam Basic Information List
Table 90. Abcam Description and Business Overview
Table 91. Abcam NARS Antibody Products, Services and Solutions
Table 92. Revenue (US$ Million) in NARS Antibody Business of Abcam (2018-2023)
Table 93. Abcam Recent Developments
Table 94. Novus Biologicals Basic Information List
Table 95. Novus Biologicals Description and Business Overview
Table 96. Novus Biologicals NARS Antibody Products, Services and Solutions
Table 97. Revenue (US$ Million) in NARS Antibody Business of Novus Biologicals (2018-2023)
Table 98. Novus Biologicals Recent Developments
Table 99. ProSci Basic Information List
Table 100. ProSci Description and Business Overview
Table 101. ProSci NARS Antibody Products, Services and Solutions
Table 102. Revenue (US$ Million) in NARS Antibody Business of ProSci (2018-2023)
Table 103. ProSci Recent Developments
Table 104. ABclonal Technology Basic Information List
Table 105. ABclonal Technology Description and Business Overview
Table 106. ABclonal Technology NARS Antibody Products, Services and Solutions
Table 107. Revenue (US$ Million) in NARS Antibody Business of ABclonal Technology (2018-2023)
Table 108. ABclonal Technology Recent Developments
Table 109. Abnova Corporation Basic Information List
Table 110. Abnova Corporation Description and Business Overview
Table 111. Abnova Corporation NARS Antibody Products, Services and Solutions
Table 112. Revenue (US$ Million) in NARS Antibody Business of Abnova Corporation (2018-2023)
Table 113. Abnova Corporation Recent Developments
Table 114. Bioss Basic Information List
Table 115. Bioss Description and Business Overview
Table 116. Bioss NARS Antibody Products, Services and Solutions
Table 117. Revenue (US$ Million) in NARS Antibody Business of Bioss (2018-2023)
Table 118. Bioss Recent Developments
Table 119. OriGene Technologies Basic Information List
Table 120. OriGene Technologies Description and Business Overview
Table 121. OriGene Technologies NARS Antibody Products, Services and Solutions
Table 122. Revenue (US$ Million) in NARS Antibody Business of OriGene Technologies (2018-2023)
Table 123. OriGene Technologies Recent Developments
Table 124. Leading Biology Basic Information List
Table 125. Leading Biology Description and Business Overview
Table 126. Leading Biology NARS Antibody Products, Services and Solutions
Table 127. Revenue (US$ Million) in NARS Antibody Business of Leading Biology (2018-2023)
Table 128. Leading Biology Recent Developments
Table 129. United States Biological Basic Information List
Table 130. United States Biological Description and Business Overview
Table 131. United States Biological NARS Antibody Products, Services and Solutions
Table 132. Revenue (US$ Million) in NARS Antibody Business of United States Biological (2018-2023)
Table 133. United States Biological Recent Developments
Table 134. Sino Biological Basic Information List
Table 135. Sino Biological Description and Business Overview
Table 136. Sino Biological NARS Antibody Products, Services and Solutions
Table 137. Revenue (US$ Million) in NARS Antibody Business of Sino Biological (2018-2023)
Table 138. Sino Biological Recent Developments
Table 139. HUABIO Basic Information List
Table 140. HUABIO Description and Business Overview
Table 141. HUABIO NARS Antibody Products, Services and Solutions
Table 142. Revenue (US$ Million) in NARS Antibody Business of HUABIO (2018-2023)
Table 143. HUABIO Recent Developments
Table 144. NSJ Bioreagents Basic Information List
Table 145. NSJ Bioreagents Description and Business Overview
Table 146. NSJ Bioreagents NARS Antibody Products, Services and Solutions
Table 147. Revenue (US$ Million) in NARS Antibody Business of NSJ Bioreagents (2018-2023)
Table 148. NSJ Bioreagents Recent Developments
Table 149. Jingjie PTM BioLab Basic Information List
Table 150. Jingjie PTM BioLab Description and Business Overview
Table 151. Jingjie PTM BioLab NARS Antibody Products, Services and Solutions
Table 152. Revenue (US$ Million) in NARS Antibody Business of Jingjie PTM BioLab (2018-2023)
Table 153. Jingjie PTM BioLab Recent Developments
Table 154. Beijing Solarbio Basic Information List
Table 155. Beijing Solarbio Description and Business Overview
Table 156. Beijing Solarbio NARS Antibody Products, Services and Solutions
Table 157. Revenue (US$ Million) in NARS Antibody Business of Beijing Solarbio (2018-2023)
Table 158. Beijing Solarbio Recent Developments
Table 159. Wuhan Fine Biotech Basic Information List
Table 160. Wuhan Fine Biotech Description and Business Overview
Table 161. Wuhan Fine Biotech NARS Antibody Products, Services and Solutions
Table 162. Revenue (US$ Million) in NARS Antibody Business of Wuhan Fine Biotech (2018-2023)
Table 163. Wuhan Fine Biotech Recent Developments
Table 164. North America NARS Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 165. North America NARS Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 166. Europe NARS Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 167. Europe NARS Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 168. Asia-Pacific NARS Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 169. Asia-Pacific NARS Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 170. Asia-Pacific NARS Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 171. Asia-Pacific NARS Antibody Market Share by Region (2018-2023)
Table 172. Asia-Pacific NARS Antibody Market Share by Region (2024-2033)
Table 173. Latin America NARS Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 174. Latin America NARS Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 175. Latin America NARS Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 176. Middle East & Africa NARS Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 177. Middle East & Africa NARS Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 178. Middle East & Africa NARS Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 179. NARS Antibody Market Trends
Table 180. NARS Antibody Market Drivers
Table 181. NARS Antibody Market Challenges
Table 182. NARS Antibody Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NARS Antibody Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global NARS Antibody Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global NARS Antibody Market Share by Regions: 2022 VS 2033
Figure 4. Global NARS Antibody Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America NARS Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe NARS Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific NARS Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America NARS Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa NARS Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Monoclonal
Figure 11. Global Monoclonal Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Polyclonal
Figure 13. Global Polyclonal Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global NARS Antibody Market Size Share by Type: 2022 & 2033
Figure 15. North America NARS Antibody Revenue Market Share by Type (2018-2033)
Figure 16. Europe NARS Antibody Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific NARS Antibody Revenue Market Share by Type (2018-2033)
Figure 18. Latin America NARS Antibody Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa NARS Antibody Revenue Market Share by Type (2018-2033)
Figure 20. Immunochemistry (IHC) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Immunofluorescence (IF) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Immunoprecipitation (IP) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Western Blot (WB) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. ELISA Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global NARS Antibody Market Size Share by Application: 2022 & 2033
Figure 27. North America NARS Antibody Revenue Market Share by Application (2018-2033)
Figure 28. Europe NARS Antibody Revenue Market Share by Application (2018-2033)
Figure 29. Asia-Pacific NARS Antibody Revenue Market Share by Application (2018-2033)
Figure 30. Latin America NARS Antibody Revenue Market Share by Application (2018-2033)
Figure 31. Middle East and Africa NARS Antibody Revenue Market Share by Application (2018-2033)
Figure 32. NARS Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players NARS Antibody Market Share in 2022
Figure 34. North America NARS Antibody Market Share by Country (2018-2033)
Figure 35. United States NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 36. Canada NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 37. Germany NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 38. France NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 39. U.K. NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 40. Italy NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 41. Russia NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 42. Nordic Countries NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific NARS Antibody Market Share by Region (2018-2033)
Figure 44. China NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 45. Japan NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 46. South Korea NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 47. Southeast Asia NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 48. India NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 49. Australia NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 50. Latin America NARS Antibody Market Share by Country (2018-2033)
Figure 51. Mexico NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 52. Brazil NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa NARS Antibody Market Share by Country (2018-2033)
Figure 54. Turkey NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 56. UAE NARS Antibody Market Size (2018-2033) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report